Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium
· Delayed Price · Currency is EUR 5.82
+0.22 (3.88%)
May 13, 2025, 3:48 PM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €156.80 million as of May 13, 2025. Its market cap has decreased by -52.14% in one year.
Market Cap
156.80M
Enterprise Value
134.47M
Revenue
9.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.82
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 156.80M, a decrease of -35.92%. That is a compound annual growth rate of -8.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 156.80M | -14.37% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | 245.41M | 0.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 30.29B |
| UCB SA | 30.09B |
| Financière de Tubize | 5.43B |
| Fagron NV | 1.56B |
| Ion Beam Applications | 335.06M |
| Nyxoah | 203.98M |
| Onward Medical | 190.41M |
| Sequana Medical NV | 58.13M |